Skip to main content

Prescription Drugs: Licensing

Volume 498: debated on Monday 26 October 2009

To ask the Secretary of State for Health what guidance his Department provides to primary care trusts on making decisions about the post-licence use of new medicines; and if he will make a statement. (295037)

The Government have issued a statutory funding direction which, unless it has been amended or waived for a specific treatment, requires national health service organisations to make funding available for treatments recommended by the National Institute for Health and Clinical Excellence (NICE) within three months of publication of final technology appraisal guidance.

New statutory directions were issued to primary care trusts and NHS trusts concerning decisions about medicines and other treatments where there is no positive NICE recommendation. These came into force on 1 April 2009 and are supported by guiding principles and good practice guidance.